FIELD: medicine.
SUBSTANCE: cystic bile recovered by fractional duodenal intubation is analysed for the concentration of cholic acid, phospholipids, cholesterol, bilirubin with calculating cholate- cholesterol (CCC) and phospholipid- cholesterol (FCC) coefficients. If observing decreasing cholic acid to 14.13±2.54 mmol/l, phospholipids to 1.62±0.27 mmol/l, bilirubin to 1.94±0.24 mmol/l, and increasing cholesterol to 9.04+1.35 mmol/l, decreasing the CCC to 1.59±0.22 and the FCC to 0.18+0.027, more severe clinical form of psoriasis, mainly erythrodermatitis developing is predicted.
EFFECT: invention provides exact prediction of transition of plaque psoriasis accompanied with chronic acalculous cholecystitis to erythrodermatitis.
4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF CLINICAL COURSE OF PSORIASIS | 2011 |
|
RU2461007C1 |
METHOD OF LABORATORY DIAGNOSTICS OF FUNCTIONAL PATHOLOGY OF LIVER ON ADULTS WITH PSORIASIS | 2017 |
|
RU2678765C1 |
METHOD FOR PREDICTION OF DETERIORATION PROBABILITY OF CLINICAL COURSE OF PSORIASIS, PROGRESSION INTO ERYTHRODERMA CONSIDERING IMMUNOLOGICAL VALUES, LIVER DETOXIFICATION AND METABOLIC FUNCTIONS | 2012 |
|
RU2508903C1 |
PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
METHOD OF TREATING PATIENTS SUFFERING PSORIASIS COMBINED WITH CHRONIC OPISTHORCHOSIS | 2009 |
|
RU2410096C1 |
METHOD OF CHOLELITHIASIS TREATMENT | 1997 |
|
RU2144347C1 |
METHOD OF TREATING PSORIATIC ERYTHRODERMA | 2011 |
|
RU2496498C2 |
METHOD OF TREATING PATIENTS WITH PSORIASIS | 2009 |
|
RU2412681C2 |
METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
METHOD OF CURE FOR ERYTHRODERMA PSORIATICUM | 2008 |
|
RU2369394C1 |
Authors
Dates
2011-03-20—Published
2009-10-12—Filed